[go: up one dir, main page]

UY33018A - Metodo de prediccion de caudal de accesos sobre linea digital asimetrica - Google Patents

Metodo de prediccion de caudal de accesos sobre linea digital asimetrica

Info

Publication number
UY33018A
UY33018A UY0001033018A UY33018A UY33018A UY 33018 A UY33018 A UY 33018A UY 0001033018 A UY0001033018 A UY 0001033018A UY 33018 A UY33018 A UY 33018A UY 33018 A UY33018 A UY 33018A
Authority
UY
Uruguay
Prior art keywords
digital line
asymmetric digital
flow prediction
access flow
access
Prior art date
Application number
UY0001033018A
Other languages
English (en)
Inventor
Fretzen Angelika
Mark G Currie
Kessler Marco
Daniel P Zimmer
Original Assignee
Telefonica Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43503086&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY33018(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Telefonica Sa filed Critical Telefonica Sa
Publication of UY33018A publication Critical patent/UY33018A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)

Abstract

La presente invención se refiere a un método de predicción de las prestaciones de un par metálico para accesos de banda ancha a partir de mediciones de reflectometría efectuadas desde un único punto de la red de acceso, concretamente desde la central telefónica, pudiendo realizarse dicho método a partir de los datos en bruto aportados por el DSLAM, así como a partir de datos ya elaborados por herramientas de gestión y configuración
UY0001033018A 2009-11-09 2010-11-09 Metodo de prediccion de caudal de accesos sobre linea digital asimetrica UY33018A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25926409P 2009-11-09 2009-11-09

Publications (1)

Publication Number Publication Date
UY33018A true UY33018A (es) 2011-01-31

Family

ID=43503086

Family Applications (2)

Application Number Title Priority Date Filing Date
UY0001033017A UY33017A (es) 2009-11-09 2010-11-09 Tratamiento para trastornos gastrointestinales
UY0001033018A UY33018A (es) 2009-11-09 2010-11-09 Metodo de prediccion de caudal de accesos sobre linea digital asimetrica

Family Applications Before (1)

Application Number Title Priority Date Filing Date
UY0001033017A UY33017A (es) 2009-11-09 2010-11-09 Tratamiento para trastornos gastrointestinales

Country Status (26)

Country Link
US (3) US20140179607A9 (es)
EP (1) EP2499154B1 (es)
JP (1) JP5913115B2 (es)
KR (1) KR20120115495A (es)
CN (1) CN102812038B (es)
AR (1) AR078950A1 (es)
AU (1) AU2010314866B2 (es)
BR (1) BR112012011730A2 (es)
CA (1) CA2779482A1 (es)
CL (1) CL2012001186A1 (es)
CO (1) CO6551683A2 (es)
CR (1) CR20120303A (es)
EA (1) EA022817B1 (es)
EC (1) ECSP12011962A (es)
ES (1) ES2620153T3 (es)
GE (1) GEP20166435B (es)
IL (1) IL219596A0 (es)
MX (2) MX350046B (es)
NZ (1) NZ599751A (es)
PH (1) PH12012500916B1 (es)
SG (1) SG10201407403UA (es)
TW (1) TWI482626B (es)
UA (1) UA114274C2 (es)
UY (2) UY33017A (es)
WO (1) WO2011057272A1 (es)
ZA (1) ZA201203342B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008151257A2 (en) 2007-06-04 2008-12-11 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US8034782B2 (en) 2008-07-16 2011-10-11 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2810951B1 (en) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010065524A2 (en) * 2008-12-02 2010-06-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of fluid retention disorders
MX350046B (es) * 2009-11-09 2017-08-24 Ironwood Pharmaceuticals Inc Tratamientos para trastornos gastrointestinales.
WO2011071927A2 (en) * 2009-12-07 2011-06-16 Ironwood Pharmaceuticals, Inc. Treatments for gastrointestinal disorders
CA2835624A1 (en) * 2011-05-11 2012-11-15 Ironwood Pharmaceuticals, Inc. Treatments for gastrointestinal disorders
US9303066B2 (en) 2011-05-11 2016-04-05 Ironwood Pharmaceuticals, Inc. Treatments for gastrointestinal disorders
US20160213739A1 (en) * 2011-05-11 2016-07-28 Ironwood Pharmaceuticals, Inc Treatments for disorders using guanylate cyclase c agonists
US9617305B2 (en) 2011-06-08 2017-04-11 Ironwood Pharmaceuticals, Inc. Treatments for gastrointestinal disorders
WO2012170766A1 (en) * 2011-06-08 2012-12-13 Ironwood Pharmaceuticals, Inc. Treatments for gastrointestinal disorders
PL2776055T3 (pl) * 2011-08-17 2017-06-30 Ironwood Pharmaceuticals, Inc. Sposoby leczenia zaburzeń żołądkowo-jelitowych
WO2014088623A1 (en) * 2012-07-12 2014-06-12 Forest Laboratories Holdings Limited Linaclotide compositions
US9708367B2 (en) * 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
CN114404588A (zh) 2013-08-09 2022-04-29 阿德利克斯公司 用于抑制磷酸盐转运的化合物和方法
AU2014331812B2 (en) * 2013-10-09 2019-01-17 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for downregulation of pro-inflammatory cytokines
WO2016015055A1 (en) * 2014-07-25 2016-01-28 Ironwood Pharmaceuticals, Inc. Colon cleansing compositions
EP3972599B1 (en) 2019-05-21 2025-10-22 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB290795A (en) 1927-04-08 1928-05-24 British Colour Printing Compan Improvements in or relating to advertising or display devices
US5518888A (en) * 1993-10-26 1996-05-21 Thomas Jefferson University ST receptor binding compounds and methods of using the same
US5601990A (en) * 1994-09-13 1997-02-11 Thomas Jefferson University Methods of diagnosing colorectal tumors and metastasis thereof
EP0734264B1 (en) * 1993-10-26 2004-02-18 Thomas Jefferson University Compositions that specifically bind to colorectal cancer cells and methods of using the same
US5879656A (en) * 1993-10-26 1999-03-09 Thomas Jefferson University Methods of treating metastatic colorectal cancer with ST receptor binding compounds
US5962220A (en) * 1993-10-26 1999-10-05 Thomas Jefferson University Compositions that specifically bind to colorectal cells and methods of using the same
CH689139A5 (de) 1995-04-03 1998-10-30 Cerbios Pharma Sa Verfahren zur Herstellung einer liposomalen, in Wasser dispergierbaren, oral zu verabreichenden, festen, trockenen therapeutischen Formulierung.
US5912014A (en) 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
WO2001080871A2 (de) * 2000-04-22 2001-11-01 Ipf Pharmaceuticals Gmbh Anwendung von guanylat-zyklase-c (gc-c) agonisten als insulinotrope faktoren zur behandlung von diabetes mellitus typ 2
US7304036B2 (en) * 2003-01-28 2007-12-04 Microbia, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US7371727B2 (en) * 2003-01-28 2008-05-13 Microbia, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US7772188B2 (en) * 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
DE602004028678D1 (de) * 2003-01-28 2010-09-23 Ironwood Pharmaceuticals Inc Zusammensetzungen zur Behandlung von Magen-Darm-Störungen
CA2619650A1 (en) * 2005-08-19 2007-02-22 Microbia, Inc. Methods and compositions for the treatment of gastrointestinal disorders
WO2008151257A2 (en) 2007-06-04 2008-12-11 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2328601B1 (en) * 2008-08-15 2020-01-22 Ironwood Pharmaceuticals, Inc. Linaclotide-containing formulations for oral administration
US20120039949A1 (en) * 2008-09-04 2012-02-16 Ironwood Pharmaceuticals, Inc. Stable Solid Formulations of GC-C Receptor Agonist Polypeptides Suitable for Oral Administration
MX350046B (es) * 2009-11-09 2017-08-24 Ironwood Pharmaceuticals Inc Tratamientos para trastornos gastrointestinales.
EP2605786A4 (en) 2010-06-09 2014-03-12 Combimab Inc THERAPEUTIC PEPTIDES

Also Published As

Publication number Publication date
EA201290322A1 (ru) 2013-01-30
MX2012005368A (es) 2012-06-13
EA022817B1 (ru) 2016-03-31
US20110118184A1 (en) 2011-05-19
WO2011057272A1 (en) 2011-05-12
UY33017A (es) 2011-06-30
US8507447B2 (en) 2013-08-13
KR20120115495A (ko) 2012-10-18
MX350046B (es) 2017-08-24
CO6551683A2 (es) 2012-10-31
ZA201203342B (en) 2013-01-30
SG10201407403UA (en) 2014-12-30
TWI482626B (zh) 2015-05-01
CN102812038B (zh) 2016-05-18
JP2013510182A (ja) 2013-03-21
CN102812038A (zh) 2012-12-05
CL2012001186A1 (es) 2013-07-12
ES2620153T3 (es) 2017-06-27
AR078950A1 (es) 2011-12-14
US20140024593A1 (en) 2014-01-23
CR20120303A (es) 2012-08-08
EP2499154B1 (en) 2016-12-21
AU2010314866B2 (en) 2014-10-30
EP2499154A1 (en) 2012-09-19
IL219596A0 (en) 2012-06-28
PH12012500916B1 (en) 2018-03-23
CA2779482A1 (en) 2011-05-12
UA114274C2 (uk) 2017-05-25
ECSP12011962A (es) 2012-07-31
TW201116291A (en) 2011-05-16
US8946158B2 (en) 2015-02-03
GEP20166435B (en) 2016-02-25
US20140179607A9 (en) 2014-06-26
NZ599751A (en) 2014-08-29
PH12012500916A1 (en) 2018-01-29
JP5913115B2 (ja) 2016-05-11
AU2010314866A1 (en) 2012-05-31
US20130085107A1 (en) 2013-04-04
BR112012011730A2 (pt) 2016-03-08

Similar Documents

Publication Publication Date Title
UY33018A (es) Metodo de prediccion de caudal de accesos sobre linea digital asimetrica
EP2602960A4 (en) COMMUNICATION METHOD AND SYSTEM FOR A NEW NETWORK
BR112013010107A2 (pt) desempenho de serviço em rede de comunicações
PH12016500039A1 (en) Communication system and apparatus
EP2092765A4 (en) PROVIDING INTERACTION MANAGEMENT FOR TELECOMMUNICATION NETWORKS
HUE042485T2 (hu) Eljárás egy hálózati cellán keresztül elérhetetlen szolgáltatáshoz való hozzáférésre
EP2198570A4 (en) High performance network adapter (hpna)
DK2493134T3 (da) Teknikker til håndtering af netværkstrafik
BR112013016199A2 (pt) capacidade de canal de múltiplas faixas para rede medidores
BRPI1014790A2 (pt) "eventos baseados em métrica para redes sociais"
EP2618593A4 (en) OPTICAL NETWORK UNIT FOR OPTICAL PATH NETWORK
EP2896174A4 (en) PHYSICAL LAYER (PHY) LINK SIGNALING FOR CABLE NETWORKS
EP2929480A4 (en) PRIVACY POLICY FOR SOCIAL NETWORKS
EP2599052A4 (en) MAKE RELATIONSHIP BETWEEN SOCIAL NETWORK SERVICES
AR078946A1 (es) Metodo de prediccion de caudal en accesos sobre linea digital asimetrica
FR2942090B1 (fr) Reseau de telecommunication
EP3746905A4 (en) NETWORK DEVICE DATA EXCHANGE COORDINATION
EP2285695A4 (en) BAND GUIDE CONTINUES
EP3858020A4 (en) GROUP BROADCAST FOR SIDE LINK COMMUNICATION
GB202303524D0 (en) Location based social network
FI20095176A0 (fi) Tietoliikenneverkon hallinta
DE112010004147A5 (de) Steuerung eines für ein telekommunikationsnetz eingerichteten dienstes
GB201907190D0 (en) Location based foreign exchange social network
FI8889U1 (fi) Viestintäverkko
CN301131054S (zh) 景观通信塔(烽火系列e型)

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20180111